FDA NDC Directory · JSON-LD · Markdown

Alhemo

NDC 0169-2081 · HUMAN PRESCRIPTION DRUG · INJECTION, SOLUTION

Generic nameconcizumab
Labeler / ManufacturerNovo Nordisk
Marketing categoryBiologic License Application · App BLA761315
Dosage form / routeINJECTION, SOLUTION · SUBCUTANEOUS
Active ingredientsCONCIZUMAB (100 mg/mL)
Marketing started20250219
Package count1

External sources

Source: openFDA. Public-domain (CC0).